American Century Companies’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
Other funds holding AVIR
BCM
VCM
American Century Companies's AVIR Position: Q2 2026 in Review
American Century Companies increased its Atea Pharmaceuticals (AVIR) stake by 2% in Q2 2026, buying an estimated $17K and bringing the position to 170,657 shares worth $794K. The position accounts for ﹤0.01% of the portfolio, ranked #2475.
American Century Companies first reported a position in AVIR in Q3 2021 and has held it in 20 quarters since. The position peaked at $2.39M in Q3 2021. 83 funds tracked by Wall St. Rank hold AVIR as of Q2 2026.
- American Century Companies held 170,657 shares of Atea Pharmaceuticals worth $794K as of Q2 2026.
- American Century Companies bought 3,427 Atea Pharmaceuticals shares in Q2 2026, an estimated $17K.
- Atea Pharmaceuticals made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2475 holding.
- American Century Companies first reported a position in Atea Pharmaceuticals in Q3 2021 and has held it in 20 quarters since.
- American Century Companies's Atea Pharmaceuticals position peaked at $2.39M in Q3 2021.
- 83 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q2 2026.
Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.